Cargando…
Prioritization of family member sequencing for the detection of rare variants
BACKGROUND: The advent of affordable sequencing has enabled researchers to discover many variants contributing to disease, including rare variants. There are methods for determining the most informative individuals for sequencing, but the application of these methods is more complex when working wit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133500/ https://www.ncbi.nlm.nih.gov/pubmed/27980641 http://dx.doi.org/10.1186/s12919-016-0035-8 |
_version_ | 1782471275307859968 |
---|---|
author | Sippy, Rachel Kolesar, Jill M Darst, Burcu F Engelman, Corinne D |
author_facet | Sippy, Rachel Kolesar, Jill M Darst, Burcu F Engelman, Corinne D |
author_sort | Sippy, Rachel |
collection | PubMed |
description | BACKGROUND: The advent of affordable sequencing has enabled researchers to discover many variants contributing to disease, including rare variants. There are methods for determining the most informative individuals for sequencing, but the application of these methods is more complex when working with families. Sets of large families can be beneficial in finding rare variants, but it may be unfeasible to sequence all members of these family sets. METHODS: Using simulated data from the Genetic Analysis Workshop 19, we apply multiple regression to identify cases and controls. To find the best controls for each case, we used kinship coefficients to match within families. Selected cases and controls were analyzed for rare variants, collapsed by gene, associated with hypertension using the family-based rare variant association test (FARVAT). RESULTS: The gene with the strongest simulated effect, MAP4, did not meet the Bonferroni corrected significance threshold. However, analysis of cases and controls using our selection method substantially improved the significance of MAP4, despite the reduction in sample size. CONCLUSIONS: Taking the additional steps to select the optimal cases and controls from large family data sets can help ensure that only informative individuals are included in analysis and may improve the ability to detect rare variants. |
format | Online Article Text |
id | pubmed-5133500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51335002016-12-15 Prioritization of family member sequencing for the detection of rare variants Sippy, Rachel Kolesar, Jill M Darst, Burcu F Engelman, Corinne D BMC Proc Proceedings BACKGROUND: The advent of affordable sequencing has enabled researchers to discover many variants contributing to disease, including rare variants. There are methods for determining the most informative individuals for sequencing, but the application of these methods is more complex when working with families. Sets of large families can be beneficial in finding rare variants, but it may be unfeasible to sequence all members of these family sets. METHODS: Using simulated data from the Genetic Analysis Workshop 19, we apply multiple regression to identify cases and controls. To find the best controls for each case, we used kinship coefficients to match within families. Selected cases and controls were analyzed for rare variants, collapsed by gene, associated with hypertension using the family-based rare variant association test (FARVAT). RESULTS: The gene with the strongest simulated effect, MAP4, did not meet the Bonferroni corrected significance threshold. However, analysis of cases and controls using our selection method substantially improved the significance of MAP4, despite the reduction in sample size. CONCLUSIONS: Taking the additional steps to select the optimal cases and controls from large family data sets can help ensure that only informative individuals are included in analysis and may improve the ability to detect rare variants. BioMed Central 2016-10-18 /pmc/articles/PMC5133500/ /pubmed/27980641 http://dx.doi.org/10.1186/s12919-016-0035-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Proceedings Sippy, Rachel Kolesar, Jill M Darst, Burcu F Engelman, Corinne D Prioritization of family member sequencing for the detection of rare variants |
title | Prioritization of family member sequencing for the detection of rare variants |
title_full | Prioritization of family member sequencing for the detection of rare variants |
title_fullStr | Prioritization of family member sequencing for the detection of rare variants |
title_full_unstemmed | Prioritization of family member sequencing for the detection of rare variants |
title_short | Prioritization of family member sequencing for the detection of rare variants |
title_sort | prioritization of family member sequencing for the detection of rare variants |
topic | Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133500/ https://www.ncbi.nlm.nih.gov/pubmed/27980641 http://dx.doi.org/10.1186/s12919-016-0035-8 |
work_keys_str_mv | AT sippyrachel prioritizationoffamilymembersequencingforthedetectionofrarevariants AT kolesarjillm prioritizationoffamilymembersequencingforthedetectionofrarevariants AT darstburcuf prioritizationoffamilymembersequencingforthedetectionofrarevariants AT engelmancorinned prioritizationoffamilymembersequencingforthedetectionofrarevariants |